AzTrials
AzTrials

Postoperative PainNCT07787221

QL Block Versus EO Plane Block for Analgesia After Open Nephrectomy

A study testing Quadratus Lumborum Block (QLB) and External Oblique Plane Block in people with Postoperative Pain, run by Cairo University at 2 sites in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This prospective randomized clinical trial aims to compare two ultrasound-guided regional anesthesia techniques, the transmuscular quadratus lumborum (QL) block and the external oblique (EO) plane block, for pain relief after open nephrectomy. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Postoperative Pain
What is being tested?
Quadratus Lumborum Block (QLB) and External Oblique Plane Block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
54 participants
Where
2 sitesEgypt
Study dates
1 Apr 2026to 1 May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients aged 18 to 65 years.
  • Patients undergoing open nephrectomy at the National Cancer Institute, Cairo University.
  • American Society of Anesthesiologists (ASA) physical status II-III.
  • Body mass index (BMI) greater than 20 kg/m² and less than 35 kg/m².

Who cannot join

  • Patient refusal to participate.
  • ASA physical status IV.
  • Age less than 18 years or greater than 65 years.
  • BMI less than 20 kg/m² or greater than 35 kg/m².
  • Known allergy or contraindication to any study medication, including local anesthetics or opioids.
  • History of psychiatric disorders or chronic pain.
  • Contraindications to regional anesthesia, including local infection at the injection site, pre-existing neuropathy, or coagulopathy.
  • Severe organ dysfunction, including cardiac dysfunction (ejection fraction <40%), respiratory dysfunction (FEV1 <50% of predicted or requirement for home oxygen therapy), hepatic dysfunction (Child-Pugh class C), or renal dysfunction (estimated glomerular filtration rate <30 mL/min/1.73 m²).

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Nourhan R Ali Hassan, Master's contact

002-01200858194

nourhanrabeaali@gmail.com

Egypt2 sites, 2 recruiting
  • Cairo University

    Cairo, 11796

    sayed M Abed, MD, 002-01226806532, sayed.abed@nci.cu.edu.eg

    Nourhan R Ali Hassan, Master's, 002-01200858194, nourhanrabeaali@gmail.com

    Recruiting
  • Cairo University

    Cairo

    sayed M Abed, MD, 002-01226806532, sayed.abed@nci.cu.edu.eg

    Nourhan R Ali Hassan, Master's, 002-01200858194, nourhanrabeaali@gmail.com

    Recruiting

Other trials in Egypt

About this study

Official title: Quadratus Lumborum Block Versus External Oblique Plane Block for Analgesia After Open Nephrectomy: A Prospective Randomized Clinical Trial

This prospective randomized clinical trial aims to compare two ultrasound-guided regional anesthesia techniques, the transmuscular quadratus lumborum (QL) block and the external oblique (EO) plane block, for pain relief after open nephrectomy. Open nephrectomy is a major surgical procedure that can cause significant postoperative pain and may require opioid medications for adequate pain control.

Adult patients undergoing open nephrectomy at the National Cancer Institute, Cairo University, who meet the study eligibility criteria will be randomly assigned to receive either a QL block or an EO plane block before surgery. Both techniques will be performed under ultrasound guidance using bupivacaine in addition to standardized general anesthesia and multimodal postoperative analgesia.

Read more

The main purpose of the study is to determine whether the QL block provides better postoperative analgesia than the EO plane block. The primary outcome will be the total amount of intravenous morphine consumed during the first 24 hours after surgery. Secondary outcomes will include postoperative pain scores, time to first request for rescue analgesia, hemodynamic changes, recovery time, patient satisfaction, and adverse effects related to analgesia or the regional anesthesia techniques.

A total of 54 patients will be enrolled and randomly allocated equally between the two treatment groups.

Read the detailed description

The study is a prospective, randomized clinical trial designed to compare the analgesic efficacy of the transmuscular quadratus lumborum block with the external oblique plane block in adult patients undergoing open nephrectomy.

Open nephrectomy is associated with substantial postoperative pain because of the extent of the surgical incision, muscular dissection, and manipulation of retroperitoneal structures. Effective postoperative analgesia is important to facilitate recovery, mobilization, respiratory function, and patient comfort while minimizing opioid requirements.

The quadratus lumborum block is a posterior abdominal wall fascial plane block in which local anesthetic is deposited in relation to the quadratus lumborum muscle. The technique may provide analgesia over several thoracoabdominal dermatomes and may have both somatic and visceral analgesic effects. The external oblique plane block is a more superficial fascial plane technique that targets the lateral abdominal wall and may provide effective somatic analgesia.

Eligible patients will be randomly allocated in a 1:1 ratio to receive either a transmuscular QL block or an EO plane block before induction of general anesthesia. All patients will receive standardized general anesthesia and multimodal postoperative analgesia. The regional blocks will be performed under ultrasound guidance by an experienced anesthesiologist.

The primary outcome is total intravenous morphine consumption during the first 24 postoperative hours. Secondary outcomes include pain intensity at predefined postoperative time points, both at rest and with movement; time to first request for rescue analgesia; intraoperative and postoperative hemodynamic changes; recovery time; patient satisfaction; and adverse effects, including nausea, vomiting, respiratory depression, and complications related to the regional anesthesia technique.

The study will evaluate whether the QL block provides superior postoperative analgesia and opioid-sparing effects compared with the EO plane block following open nephrectomy.

Being tested
Quadratus Lumborum Block (QLB), External Oblique Plane Block
Keywords
Nephrectomy, Quadratus Lumborum Block, Regional Anesthesia
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Quadratus Lumborum Block (QLB)Procedure or surgery

    Ultrasound-guided transmuscular quadratus lumborum block using 30 mL of 0.25% bupivacaine administered before induction of general anesthesia.

  • External Oblique Plane BlockProcedure or surgery

    Ultrasound-guided external oblique plane block using 30 mL of 0.25% bupivacaine administered before induction of general anesthesia.

Study groups in NCT07787221
Study groupRoleWhat they receive
Quadratus Lumborum Block (QL)ExperimentalParticipants will receive an ultrasound-guided transmuscular quadratus lumborum block before induction of general anesthesia. A total of 30 mL of 0.25% bupivacaine will be administered in the fascial plane between the quadratus lumborum and psoas major muscles. Participants will also receive the standardized general anesthesia and postoperative multimodal analgesia described in the study protoco
Receives: Procedure: Quadratus Lumborum Block (QLB)
External Oblique Plane Block (EO)ExperimentalParticipants will receive an ultrasound-guided external oblique plane block before induction of general anesthesia. A total of 30 mL of 0.25% bupivacaine will be administered in the fascial plane between the external oblique and intercostal muscles. Participants will also receive the standardized general anesthesia and postoperative multimodal analgesia described in the study protocol.
Receives: Procedure: External Oblique Plane Block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 24-hour postoperative morphine consumption

    Total amount of intravenous morphine administered as rescue analgesia during the first 24 hours after surgery. Morphine consumption will be recorded for each participant and compared between the quadratus lumborum block and external oblique plane block groups.

    Measured: First 24 hours after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2026
  2. Study start1 Apr 2026
  3. Primary completion1 Apr 2027 (estimated)
  4. Study completion1 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned in a 1:1 ratio to one of two parallel intervention groups: transmuscular quadratus lumborum block or external oblique plane block.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
54 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07787221
Sponsor's protocol ID
QL block vs EOB in nephrectomy
Status last verified
Aug 2026
First submitted
24 Aug 2026
Last updated
1 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared with other researchers because no data-sharing plan has been established for this study. Study data will be used by the research team for the purposes of the current study, in accordance with applicable ethical and institutional requirements.

Publications

  • Blanco R, Ansari T, Girgis E. Quadratus lumborum block for postoperative pain after caesarean section: A randomised controlled trial. Eur J Anaesthesiol. 2015 Nov;32(11):812-8. doi: 10.1097/EJA.0000000000000299.

    PubMed 26225500
  • Elsharkawy H, El-Boghdadly K, Barrington M. Quadratus Lumborum Block: Anatomical Concepts, Mechanisms, and Techniques. Anesthesiology. 2019 Feb;130(2):322-335. doi: 10.1097/ALN.0000000000002524. No abstract available.

    PubMed 30688787
  • Blanco R. TAP block under ultrasound guidance: the description of a "non-pops technique." Reg Anesth Pain Med. 2007;32(2):130.

Questions about this trial

What is this clinical trial studying?

A study testing Quadratus Lumborum Block (QLB) and External Oblique Plane Block in people with Postoperative Pain, run by Cairo University at 2 sites in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sayed M Abed, MD (002-01226806532, sayed.abed@nci.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

24-hour postoperative morphine consumption (time frame: First 24 hours after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07787221, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in